BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32882433)

  • 1. NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge.
    Zhan Y; Pang Z; Du Y; Wang W; Yang Y; Wang W; Gao GF; Huang B; Deng Y; Tan W
    Infect Genet Evol; 2020 Nov; 85():104521. PubMed ID: 32882433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
    Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein.
    Li A; Yu J; Lu M; Ma Y; Attia Z; Shan C; Xue M; Liang X; Craig K; Makadiya N; He JJ; Jennings R; Shi PY; Peeples ME; Liu SL; Boyaka PN; Li J
    Nat Commun; 2018 Aug; 9(1):3067. PubMed ID: 30076287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
    Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
    EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E.
    Xiong G; Li Y; Chen F; Xiong X; Wang Q; Zhang L; Dong H; Zhu C; Cui J; He M; Cheng H; Hu A; Cheng C; Pang J; Liu G; Chen H
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109308. PubMed ID: 36274487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Live-Attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.
    Ye X; Liu X; Shu T; Deng W; Liao M; Zheng Y; Zheng X; Zhang X; Li T; Fan W; Qu L; Chen L; Li F; Feng L
    J Virol; 2021 Jun; 95(14):e0038321. PubMed ID: 33910950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
    Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
    Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W
    J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow fever vaccine protects mice against Zika virus infection.
    Vicente Santos AC; Guedes-da-Silva FH; Dumard CH; Ferreira VNS; da Costa IPS; Machado RA; Barros-Aragão FGQ; Neris RLS; Dos-Santos JS; Assunção-Miranda I; Figueiredo CP; Dias AA; Gomes AMO; de Matos Guedes HL; Oliveira AC; Silva JL
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009907. PubMed ID: 34735450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
    Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
    Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
    Zhan Y; Deng Y; Huang B; Song Q; Wang W; Yang Y; Dai L; Wang W; Yan J; Gao GF; Tan W
    Vaccine; 2019 Apr; 37(15):2122-2130. PubMed ID: 30851967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of protective immune responses against a lethal Zika virus challenge post-vaccination with a dual serotype of recombinant vesicular stomatitis virus carrying the genetically modified Zika virus E protein gene.
    Choi JA; Wu K; Kim GN; Saeedian N; Seon SH; Park G; Jung DI; Jeong HW; Kim NH; Seo SH; Lee S; Song M; Kang CY
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice.
    Grubor-Bauk B; Wijesundara DK; Masavuli M; Abbink P; Peterson RL; Prow NA; Larocca RA; Mekonnen ZA; Shrestha A; Eyre NS; Beard MR; Gummow J; Carr J; Robertson SA; Hayball JD; Barouch DH; Gowans EJ
    Sci Adv; 2019 Dec; 5(12):eaax2388. PubMed ID: 31844662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine protection against Zika virus from Brazil.
    Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
    Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-Deficient Zika Vector-Based Vaccine Provides Maternal and Fetal Protection in Mouse Model.
    Garcia G; Chakravarty N; Abu AE; Jeyachandran AV; Takano KA; Brown R; Morizono K; Arumugaswami V
    Microbiol Spectr; 2022 Oct; 10(5):e0113722. PubMed ID: 36169338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.